Farag Kameel D.
- SEC CIK
- 0002093620
No open-market purchases or sales filed in the past year.
Current role at each company
- AKTX Akari Therapeutics PlcInterim CFOas of Aug 19, 2026
- BIVI Biovie Inc.Directoras of Jan 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Farag Kameel D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKTX Akari Therapeutics Plc
Interim CFO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing)9:57 PM ET | Dec 16 | 2 days | Farag Kameel D.Interim CFO | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +49.5K | $0.4041 | +$10.0K | –24.7K after | Derivative2 lots |